Pregnant women who take the epilepsy drug valproate, also known by the brand name Depacon, may increase the risk of childhood autism and its spectrum disorders in their unborn babies, a new study suggests. Depacon is used to treat epileptic seizures and mania associated with bipolar disorder, as well as to prevent migraines. The drug already has a black box warning for increasing the risk of serious birth defects in fetuses exposed in utero. The drug’s warning label urges women of childbearing age to weigh the benefits of valporate against the risk of fetal injury, such as neural tube defects including ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.